NewGenIVF Group Ltd Files 2024 Annual Report

Ticker: NIVFW · Form: 20-F · Filed: Apr 22, 2025 · CIK: 1981662

Newgenivf Group LTD 20-F Filing Summary
FieldDetail
CompanyNewgenivf Group LTD (NIVFW)
Form Type20-F
Filed DateApr 22, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: annual-report, 20-f, healthcare

TL;DR

NewGenIVF dropped its 2024 20-F. Check financials.

AI Summary

NewGenIVF Group Ltd filed its annual report (Form 20-F) for the fiscal year ended December 31, 2024. The company, previously known as ASPAC I Mini Acquisition Corp. until June 14, 2023, is incorporated in D8 and operates in the health services sector. Its principal executive offices are located in Bangkok, Thailand, with mail addressed to Hong Kong.

Why It Matters

This filing provides investors with the company's official financial performance and operational overview for the past fiscal year, crucial for assessing its current standing and future prospects.

Risk Assessment

Risk Level: medium — As an annual report filing, it contains standard financial disclosures, but the company's specific operational risks and financial health are not detailed in this summary, requiring further review of the full document.

Key Numbers

Key Players & Entities

FAQ

What was NewGenIVF Group Ltd's previous name?

NewGenIVF Group Ltd was formerly known as ASPAC I Mini Acquisition Corp.

When did the company change its name?

The company changed its name on June 14, 2023.

What is the SEC file number for NewGenIVF Group Ltd?

The SEC file number is 001-42004.

For which fiscal year is this 20-F filing?

This 20-F filing is for the fiscal year ended December 31, 2024.

Where are NewGenIVF Group Ltd's principal executive offices located?

The principal executive offices are located at 13/F, PS Tower, Sukhumvit 21 Rd (Asoke), Bangkok.

Filing Details

This Form 20-F (Form 20-F) was filed with the SEC on April 22, 2025 regarding NewGenIvf Group Ltd (NIVFW).

View full filing on EDGAR

View Full Filing

View this 20-F filing on SEC EDGAR

View on Read The Filing